Idiopathic Pulmonary Fibrosis Cohort of TCM

Idiopathic Pulmonary Fibrosis Cohort Studies of Chinese Medicine

This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.

This study is based on a previously established registry of interstitial lung disease, with traditional Chinese medicine treatment as the exposure factor. A total of at least 1000 IPF patients will be continuously enrolled and followed up for 2 years; it will further observe the pattern of syndromes, disease characteristics, and their interrelationships during disease development, and evaluate the clinical efficacy of traditional Chinese medicine in treating IPF using indicators such as annual acute exacerbation rate and clinical symptoms. Based on the differences in efficacy indicators, it will identify the advantageous population, clarify the clinical efficacy advantage targets, and provide a basis for precision treatment with traditional Chinese medicine.

Inclusion Criteria:

1. Patients diagnosed with IPF;
2. Age ≥ 40 years old;
3. Voluntary participation in this study,And sign the informed consent form.

Exclusion Criteria:

1. Patients with confusion, dementia, consciousness disorders, and various mental illnesses;
2. Patients who are unable to take care of themselves and have been bedridden for a long time.